Patent classifications
C12Y308/01002
Method for the preparation of chiral alpha haloalkanoic acids
What is described herein relates to a method of selectively hydrolyzing an enantiomer of an alpha haloalkanoic acid according to formula I employing a polypeptide having dehalogenase activity comprising an amino acid sequence as set forth in SEQ ID NO. 1 or SEQ ID NO. 4 or a sequence with at least 80% sequence identity to either of said sequences and to the use of said method.
METHOD FOR THE PREPARATION OF CHIRAL ALPHA HALOALKANOIC ACIDS
What is described herein relates to a method of selectively hydrolyzing an enantiomer of an alpha haloalkanoic acid according to formula I employing a polypeptide having dehalogenase activity comprising an amino acid sequence as set forth in SEQ ID NO. 1 or SEQ ID NO. 4 or a sequence with at least 80% sequence identity to either of said sequences and to the use of said method.
VARIANT OF HALOACID DEHALOGENASE SUPERFAMILY PROTEIN AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN SAMPLE USING THE SAME
Provided are a variant of a haloacid dehalogenase superfamily protein, a polynucleotide encoding the variant, a recombinant microorganism including the variant, and a method of reducing a concentration of a fluorine-containing compound in a sample using the variant.
POLYNUCLEOTIDE ENCODING FUSION OF ANCHORING MOTIF AND DEHALOGENASE, HOST CELL INCLUDING THE POLYNUCLEOTIDE, AND USE THEREOF
Provided is a linked polynucleotide in which polynucleotides encoding a promoter, an anchoring motif, and a dehalogenase, respectively, are operatively linked to one another; a host cell including the linked polynucleotide; and a method of reducing a concentration of a fluorine-containing compound in a sample by using the host cell.
HALOACID DEHALOGENASE SUPERFAMILY PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN SAMPLE USING THE SAME
Provided are a haloacid dehalogenase superfamily protein variant and a method of reducing a concentration of a fluorine-containing compound in sample using the same.
MICROORGANISM INCLUDING GENE ENCODING PROTEIN HAVING DEHALOGENASE ACTIVITY, AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN SAMPLE USING THE SAME
Provided are a microorganism including a gene encoding a protein having a dehalogenase activity, a composition including the microorganism for use in reducing a concentration of a fluorine-containing compound in a sample, and a method of reducing the concentration of the fluorine-containing compound in the sample by using the microorganism.
BACILLUS SAITENS DECOMPOSING FLUORINE-CONTAINING COMPOUND, RECOMBINANT MICROORGANISM INCLUDING GENE DERIVED FROM BACILLUS SAITENS, AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN SAMPLE BY USING BACILLUS SAITENS
Provided are a microorganism having activity in reducing a concentration of a fluorine-containing compound in a sample, a recombinant microorganism including a gene derived from the microorganism, and a method of reducing the concentration of the fluorine-containing compound in the sample by using the microorganism or recombinant microorganism.
Microorganism including gene encoding protein having dehalogenase activity and method of reducing concentration of fluorinated methane in sample using the same
Provided is a microorganism including a gene encoding a protein having a dehalogenase activity, a composition for using in reducing a concentration of fluorinated methane in a sample, the composition including the microorganism including the gene encoding the protein having the dehalogenase activity, and a method of reducing the concentration of fluorinated methane in the sample.
EXHAUST GAS DECOMPOSITION APPARATUS AND EXHAUST GAS DECOMPOSITION SYSTEM INCLUDING THE SAME
An exhaust gas decomposition apparatus or system that includes a bioreactor fluorine-containing compound is decomposed by contact with the first and second fluids in the bioreactor. The first fluid is supplied through a bioreactor inlet and is exhausted through the bioreactor outlet, and moves in a first direction in the bioreactor. The first or second fluid includes a biological catalyst such as an enzyme or recombinant microbe, while the other fluid includes a fluorine-containing compound. As a result, the fluorine-compounds is efficiently biologically remediated by the biological catalyst.
RECOMBINANT MICROORGANISM INCLUDING GENETIC MODIFICATION THAT INCREASES 2-HALOACID DEHALOGENASE ACTIVITY AND METHOD OF REDUCING CONCENTRATION OF FLUORINATED METHANE IN SAMPLE BY USING THE SAME
Provided is a recombinant microorganism including a genetic modification that increases a 2-haloacid dehalogenase activity, a method of preparing the recombinant microorganism, and a method of using the recombinant microorganism for reducing the concentration of fluorinated methane in a sample.